S. Kolehmainen

Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting

J. Jokelainen, T. Jokiranta, T. Sipponen, 2021, Scandinavian journal of gastroenterology.

Impact of anti-TNF-alpha therapy on colectomy rate and indications for colectomy in ulcerative colitis: comparison of two patient cohorts from 2005 to 2007 and from 2014 to 2016*

M. Färkkilä, A. Lepistö, S. Kolehmainen, 2019, Scandinavian journal of gastroenterology.

The effect of paracetamol or diclofenac administered before operation on postoperative pain and behaviour after adenoidectomy in small children

M. Rorarius, G. Baer, S. Kolehmainen, 1992, Anaesthesia.

Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study

H. Huhtala, T. Sipponen, A. Jussila, 2022, Scandinavian journal of gastroenterology.

Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease.

E. Löyttyniemi, K. Salminen, T. Sipponen, 2024, European journal of gastroenterology & hepatology.